John Overdeck’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,930
Closed -$516K 3138
2021
Q4
$516K Buy
+9,930
New +$512K ﹤0.01% 3226
2021
Q3
Sell
-5,028
Closed -$312K 4358
2021
Q2
$312K Sell
5,028
-10,182
-67% -$679K ﹤0.01% 3476
2021
Q1
$991K Buy
15,210
+10,810
+246% +$705K ﹤0.01% 2327
2020
Q4
$289K Buy
+4,400
New +$259K ﹤0.01% 2891

Other funds holding EHC

John Overdeck's EHC Position: Q2 2026 in Review

John Overdeck increased its Encompass Health (EHC) stake by 2.1% in Q2 2026, buying an estimated $4.72M and bringing the position to 2,267,668 shares worth $229M. The position accounts for 0.17% of the portfolio, ranked #129.

John Overdeck first reported a position in EHC in Q2 2013 and has held it in 38 quarters since. 594 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • John Overdeck held 2,267,668 shares of Encompass Health worth $229M as of Q2 2026.
  • John Overdeck bought 45,567 Encompass Health shares in Q2 2026, an estimated $4.72M.
  • Encompass Health made up 0.17% of John Overdeck's portfolio in Q2 2026, its #129 holding.
  • John Overdeck first reported a position in Encompass Health in Q2 2013 and has held it in 38 quarters since.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.